A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate mutated p53. This crucial cancer suppressor protein is frequently inactivated in various forms of cancer, leading https://sites2000.com/story11815244/mini-antibodies-revive-tumor-suppressor-p53-new-promising-pathway-for-cancer-management